The Mitochondrial A10398G Polymorphism, Interaction with Alcohol Consumption, and Breast Cancer Risk by Pezzotti, Annamaria et al.
The Mitochondrial A10398G Polymorphism, Interaction
with Alcohol Consumption, and Breast Cancer Risk
Annamaria Pezzotti
1, Peter Kraft
1,2, Susan E. Hankinson





1Program in Molecular and Genetic Epidemiology, Epidemiology Department, Harvard School of Public Health, Boston, Massachusetts, United States of America,
2Biostatistics Department, Harvard School of Public Health, Boston, Massachusetts, United States of America, 3Channing Laboratory, Department of Medicine, Brigham
and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, 4Division of Preventive Medicine, Brigham and Women’s Hospital
and Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Polymorphisms in the mitochondrial genome are hypothesized to be associated with risk of various diseases, including
cancer. However, there has been conflicting evidence for associations between a common polymorphism in the
mitochondrial genome (A10398G, G10398A in some prior reports) and breast cancer risk. Reactive oxygen species, a by-
product of mitochondrial energy production, can lead to oxidative stress and DNA damage in both the mitochondria and
their cells. Alcohol consumption, which may also lead to oxidative stress, is associated with breast cancer risk. Therefore, we
hypothesized that polymorphisms in the mitochondrial genome interact with alcohol consumption to alter breast cancer
risk. We genotyped the A10398G polymorphism in a case-control study nested within the Nurses’ Health Study (NHS, 1,561
cases, 2,209 controls). We observed an interaction between alcohol consumption (yes/no) and A10398G on breast cancer
risk (p-int=0.03). The risk associated with alcohol consumption was limited to carriers of the 10398G allele (Odds Ratio 1.52,
95% Confidence Interval 1.10–2.08 comparing drinkers to non-drinkers). However, we were unable to replicate these
findings in the Women’s Health Study (WHS, 678 cases, 669 controls), although the power to detect this interaction in the
WHS was low (power=0.57). Further examination of this interaction, such as sufficiently powered epidemiological studies of
cancer risk or associations with biomarkers of oxidative stress, may provide further evidence for GxE interactions between
the A10398G mitochondrial polymorphism and alcohol consumption on breast cancer risk.
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Introduction
Mitochondria are very important cellular organelles, playing
active roles in various functions, such as energy balance and cell
cycle control. In addition, by transforming energy into a form
that the cell can use, mitochondria produce reactive oxygen
species (ROS) that can lead to damage of key components of the
cell, particularly proteins and DNA. All of these facets of
mitochondrial biology make them of interest with respect to
cancer biology.
As mitochondria were once symbiotic bacteria living within
early eukaryotes, they still carry their own genome, separate from
the nuclear genome. While many genes have been shared between
the mitochondrial and nuclear genomes of humans over
evolutionary history, the mitochondrial genome still retains many
of the genes required for its proper functioning. Like the nuclear
genome, the mitochondrial genome carries polymorphic sequenc-
es. Interestingly, it is hypothesized that polymorphisms in the
mitochondria that cause the mitochondria to be less efficient in
energy exchange, therefore creating more heat and reactive
oxygen species, allowed early humans an adaptive advantage
when migrating to cooler climates, such as from Africa to Europe
[1], and advances in genotyping and sequencing technology have
led to greater understanding and fine-scale resolution of human
migrations based on mitochondrial genetics [2]. Other polymor-
phisms have more recently been investigated for association with
various diseases, including diabetes [1,3–6], Parkinson’s disease
[7–9], Alzheimer’s disease [8,10–12], and breast cancer [13–16].
The nonsynonymous A10398G (T114A) polymorphism in the
ND3 (NADH dehydrogenase subunit) gene of the mitochondrial
genome is one of the most extensively studied mitochondrial
polymorphisms. There is no prior knowledge of this polymorphism
affectingmitochondrialfunction,howeverithasbeenassociatedwith
neurodegenerative diseases such as Parkinson’s[7] disease , Frie-
drich’s ataxia [17], and ALS[18]. Evidence of an association
between this polymorphism and breast cancer risk has been
inconclusive [13–16]. Therefore, we studied this polymorphism in
the case-control study of breast cancer nested in the prospective
Nurses’ Health Study (NHS) cohort, consisting of 1,561 cases and
2,209 controls. We also hypothesized that alcohol consumption,
which increases oxidative stress and is associated with breast cancer
risk[19], would modify the association between A10398G and breast
cancer risk. Upon observing an interaction between alcohol
consumption and A10398G on breast cancer risk, we sought to
confirm this finding in the Women’s Health Study (WHS), where
678 cases and 669 controls were successfully genotyped.
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Baseline characteristics of both the NHS and WHS are reported
in Table 1. We did not observe any association between the
A10398G polymorphism in the mitochondrial ND3 gene and
breast cancer risk in either the NHS (Odds Ratio (OR) 1.01, 95%
Confidence Interval (CI) 0.85–1.19) or WHS (OR 0.94, 95% CI
0.72–1.22) (Table 1.). Results were similar between conditional
and unconditional analyses, so we will present unconditional
analyses in order to include all samples with available data. There
was no evidence of confounding by any of the covariates included
in the models, however we have chosen to include them in all
analyses to control for even minor confounding.
Major ancestry was asked in the Nurses’ Health Study by
questionnaire in 1992 and 98% of the participants who responded
to this question are self described Caucasians. Furthermore, 659
(18% of the total) of the subjects described themselves as South
European/Mediterranean, 260 (7% of the total) as Scandinavian,
and 2603 as Other Caucasian (73% of the total). In these sub-
categories, the G allele of A10398G is present at 18.5, 18.1, and
19.7% respectively. 28 subjects described themselves as African-
American, 11 as Hispanic and 14 as Asian. In these sub-categories,
the G allele of A10398G is present at 89.3, 9.1, and 64.3%
respectively.
We did observe, however, an interaction between A10398G and
alcohol consumption (alcohol coded as non-drinkers/drinkers, p-
interaction=0.03) in the NHS. P-values from both the Wald and
Likelihood Ratio Tests (LRT) were similar (identical to the third
decimal place at 0.026), as expected. In cross-tabulated analyses,
women carrying the variant G allele and not consuming alcohol
were at decreased risk of breast cancer as compared to women not
carrying the variant and not consuming alcohol (OR 0.79, 95% CI
0.60–1.04, Table 2). The association between alcohol consump-
tion and breast cancer risk among carriers of the G allele of
A10398G in the NHS was 1.52 (95% CI 1.10–2.08, Table 2).
Restricting these analyses to self-described Caucasian participants
did not significantly alter the results, OR 1.56, 95% CI 1.12–2.16.
We did not observe this interaction in the WHS (Table 2).
However, the prevalence of alcohol consumption in the WHS
(Table 1) was lower than in the NHS, and the power to detect this
interaction in the WHS is low (power=0.57, alpha=0.05).
Combining data from both the NHS and WHS by meta-analyses
reduced the point estimate of risk of breast cancer associated with
alcohol consumption among carriers of the G allele of A10398G to
1.33, 95% CI 1.04–1.71.
Discussion
The mitochondria’s role in various cellular processes, including
production of energy and ROS, DNA damage and repair, and cell
cycle control make them likely candidates to play a role in risk of
cancer. In addition, the mitochondrial genome contains polymor-
phisms and is transmitted only from the mother to offspring.
Therefore, mitochondrial polymorphisms are strong candidates as
markers of risk for many diseases, including breast cancer.
In our discussion, we will use the terms ‘‘Caucasian’’ or
‘‘Hispanic’’ if this is how either the study subjects (with respect to
the NHS) describe themselves, or how the participants were
described in prior publications. It should be noted that the
A10398G polymorphism is of great importance with respect to
mitochondrial phylogeny, being relatively less frequent in West
Eurasian populations as opposed to African or Asian lineages[2]
and therefore population stratification with respect to this variant
should be discussed. A substantial subset of the breast cancer cases
and controls (,1150 cases and one of their matched controls) from
the Nurses’ Health Study has participated in the first stage of a
genome wide scan. In principal component analyses of over
500,000 SNPs from this scan, no population substructure (other
than that which corresponds to self-described ancestry into
‘‘Caucasian’’, ‘‘Hispanic’’, ‘‘Asian’’, and ‘‘African-American’’)
was observed[20]. Similarly, there is no heterogeneity in allele
distributions between the self-reported sub-populations reported
by the cases and controls. Further restricting our analyses to self-
described Caucasians did not substantially alter our results (OR
1.56, 95% CI 1.12–2.17 for alcohol consumption among carriers
of the G allele of A10398G). In order for population stratification
to explain the interaction observed in the NHS, such substructure
would need to be associated with both breast cancer and alcohol
consumption. Heterogeneity, either in exposure to alcohol, genetic
background (and population substructure), and baseline breast
cancer risk could explain the lack of replication of the interaction
observed in the NHS by the WHS. However, the most likely
explanation for the lack of replication is random variation in these
variables, and either a false positive interaction in the NHS or a
false negative interaction in the WHS.
One limitation of this study is that having genotyped only one
mitochondrial variant, we are unable to categorize the participants
of this study into well defined mitochondrial haplogroups as done
by Bai et al.[16] However given the prior work published on the
non-synonymous A10398G (T114A) polymorphism in the mito-
chondrial NADH dehydrogenase subunit 3 (ND3) and breast
cancer risk [13–16] coupled with the possibility of its putative
function, we feel that the a priori hypothesis of an interaction
between alcohol consumption and the A10398G polymorphism on
breast cancer risk is relatively strong.
The A allele of the A10398G polymorphism has been associated
with an increase in risk of breast cancer in African-Americans (654
cases, 605 controls, OR 1.60 (95% CI 1.10–2.93), but not among
Caucasians (879 cases, 760 controls, OR 1.03 (95% CI 0.81–1.31)
[14]. In a smaller case-control study (124 cases and 273 controls) of
women from the Indian sub-continent, Darvishi et al. also
Table 1. Baseline Characteristics of Study Participants from the Nurses’ Health Study and Women’s Health Study
Nurses’ Health Study Women’s Health Study
Cases (N=1561) Controls (N=2209) Cases (N=678) Controls (N=669)
Age (St.Dev.) 56.9 (6.96) 57.8 (6.87) 60.5 (7.60) 60.3 (7.58)
A10398G G carriers (%) 319 (20.4) 447 (20.2) 149 (22.0) 151 (22.6)
Mean alcohol consumption g/day (St. Dev.) 5.28 (9.13) 5.10 (8.82) 4.70 (8.79) 4.39 (8.90)
Alcohol consumption ever/never (%) 983 (63.0) 1358 (61.5) 390 (57.5) 362 (54.1)
doi:10.1371/journal.pone.0005356.t001
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1.73 (95% CI 1.13–2.66) [15]. While Darvishi et al. do not report
specific allele distributions in their population, the prevailing
haplogroups in their Indian population are more closely related to
the African population with respect to the allele distribution of the
A10398G polymorphism. Bai et al. studied 29 mtDNA variations
in a small case control study of breast cancer (156 women with
familial breast cancer and 260 controls). They observed an inverse
association between haplogroup U (which contains the 10398A
allele) and breast cancer risk [16]. Recently, Setiawan et al. did not
observe an association between this polymorphism and breast
cancer risk among African-American populations in California
(1456 cases and 978 controls) [13].
The Nurses’ Health Study has greater than 80% power to detect
a 26% increase (OR=1.26) in risk between the A10398G
polymorphism and breast cancer at an alpha of 0.05. Therefore,
we can exclude any association between this polymorphism and
breast cancer risk with an odds ratio above 1.26, such as those first
observed in African-Americans (OR=1.60) and Indians
(OR=1.73) in our study population. We have limited power to
detect, however, more moderate (OR,1.26) associations between
this polymorphism and breast cancer risk.
Our findings of an interaction between alcohol consumption
and A10398G in the Nurses’ Health Study are of interest. Alcohol
is a well established breast cancer risk factor [19]. A metabolite of
alcohol, acetyladehyde, is a reactive oxygen species, and increases
oxidative stress [21–23]. Given the prior epidemiologic data of
associations between A10398G and various diseases, it is
hypothesized that the G allele has lower potential to generate
reactive oxygen species. This is in concert with our observation
that women in the Nurses’ Health Study who do not consume
alcohol and carry this allele have a 21% lower risk of breast cancer
as compared to non-drinkers who do not carry the allele. An
alternative way of examining these findings with more relevance to
public health is to look at the association between alcohol
consumption within genotype categories. Among women carrying
the G allele, alcohol consumption is associated with a 56%
increase in breast cancer risk in the Nurses’ Health Study.
Further examination of the interaction between alcohol con-
sumption and the A10398G polymorphism of the mitochondrial
genome on breast cancer risk could refine our observations. While it
is hypothesized that A10398G alters the production of reactive
oxygen species in the mitochondria, there is no in vitro evidence to
date to support this hypothesis. Therefore the interaction that we
have observed between this polymorphism, which may well be
nothing more than a marker of other mitochondrial variation and
have no functional relevance specifically, and alcohol consumption
on breast cancer risk could be due to other mitochondrial
polymorphisms which occur in common with A10398G. Epidemi-
ologic studies are generally ill-suited to describe a causal marker
when multiple correlated markers, all with little if any known
functional relevance to the phenotype in question, exist.
Additional epidemiologic evidence such as evidence for
interactions between this polymorphism and/or other variants
with which it is correlated and alcohol consumption in other breast
cancer studies would also be of interest. However, the studies
would need to have sufficient power to detect such an interaction.
Similarly, as alcohol consumption is associated with other diseases
(presumably through increased oxidative stress), including other
cancer sites, it is possible that similar interactions could be
observed with risk of these diseases and should be explored.
Alternatively, interactions between this polymorphism and alcohol
consumption on markers of oxidative stress would also provide
biological evidence supporting our observations.
Table 2. Interaction between A10398G, Alcohol Consumption, and Breast Cancer Risk in the Nurses’ Health Study (NHS) and the
Women’s Health Study (WHS)
NHS Cases (%) Controls (%) OR* (95% CI)
A10398, non-Drinkers 475 (30.5) 662 (30.0) 1.00 (Ref.)
A10398, Drinkers 767 (49.2) 1100 (49.8) 1.02 (0.87–1.19)
G10398, non-Drinkers 103 (6.6) 189 (8.6) 0.79 (0.60–1.04)
G10398, Drinkers 216 (13.9) 258 (11.7) 1.18 (0.95–1.48)
A10398 Carriers Non-Drinkers 475 (38.2) 662 (37.6) 1.00 (Ref.)
Drinkers 767 (61.8) 1100 (62.4) 0.96 (0.83–1.12)
G10398 Carriers Non-Drinkers 103 (32.3) 189 (42.3) 1.00 (Ref.)
Drinkers 216 (67.9) 258 (57.7) 1.52 (1.10–2.08)
WHS Cases (%) Controls (%) OR** (95% CI)
A10398, non-Drinkers 225 (33.2) 245 (36.6) 1.00 (Ref.)
A10398, Drinkers 304 (44.8) 273 (40.8) 1.22 (0.95–1.57)
G10398, non-Drinkers 63 (9.3) 62 (9.3) 1.08 (0.73–1.62)
G10398, Drinkers 86 (12.7) 89 (13.3) 1.03 (0.72–1.46)
A10398 Carriers Non-Drinkers 225 (42.5) 245 (47.3) 1.00 (Ref.)
Drinkers 304 (57.5) 273 (52.7) 1.22 (0.95–1.57)
G10398 Carriers Non-Drinkers 63 (42.3) 62 (41.1) 1.00 (Ref.)
Drinkers 86 (57.7) 89 (58.9) 0.96 (0.60–1.53)
*Unconditional logistic regression controlling for fasting status, date and time of blood draw, age, body mass index (at blood draw and age 18), menopausal status,
family history of breast cancer and history of benign breast disease. P-interaction=0.03
**Unconditional logistic regression controlling for age, history of benign breast disease and family history of breast cancer. P-interaction=0.95
doi:10.1371/journal.pone.0005356.t002
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A10398G polymorphism in the human mitochondrial genome
and alcohol consumption associated with breast cancer risk. In the
Nurses’ Health Study, drinkers who carry the 10398G allele are at
a 56% higher risk of breast cancer than non-drinkers with the
same allele. This interaction was not observed in the Women’s
Health Study; however there was insufficient power to detect this
association in this study. Upon combining results from the NHS
and WHS, the risk of breast cancer associated with alcohol
consumption among carriers of the G allele of A10398G was
reduced to 33% (OR 1.33, 95% CI 1.04–1.71) Further
examination of the possible interaction between alcohol consump-
tion and the A10398G polymorphism, or other variants for which
it is a marker, on breast cancer risk is needed to further define this
association. Additionally, understanding of the biological signifi-
cance, if any, related to the A10398G polymorphism (or other
variants co-existing in the mitochondrial genome with A10398G)
and how it/they could interact with alcohol consumption would
also be of great interest.
Materials and Methods
The Nurses’ Health Study nested breast cancer case control
study (cases, n=1,561; controls, n=2,209) is derived from 32,826
women who were free of diagnosed breast cancer at blood
collection in 1989 and 1990, and were followed for incident
disease until May 31, 2004. Medical records were used to confirm
the diagnoses in women who reported a diagnosis of breast cancer
on the biennial questionnaires. Control subjects were matched to
cases based on age, menopausal status, recent hormone replace-
ment therapy, and blood-draw specific variables (such as date and
time of day). Questionnaires were used to determine the subject’s
major ethnic group (Caucasian, Hispanic, African-American,
Asian), as well as further detail within Europe (Mediterranean/
Southern European, Scandinavian, Other Caucasian). The nested
breast cancer case control study in the Harvard Women’s Health
Study began in 1993 when 28,263 women provided blood samples
and were followed for incident disease until March 7, 2000, with
702 cases and 703 controls selected using the same criteria as in
the NHS. Detailed descriptions of these cohorts have been
published previously, and a brief summary of the subjects in these
analyses are in Table 1.
The A10398G polymorphism in the mitochondrial genome was
genotyped using Taqman technology (Applied Biosystems, Foster
City, CA). Primer and probe sequences as well as cycling
conditions are available from the authors. Internal blinded quality
control (QC) samples were 100% concordant, and greater than
95% of samples yielded genotypes. Hardy-Weinberg equilibrium
tests are not valid for mitochondrial SNPs, and therefore were not
assessed, and no heteroplasmy (detected as heterozygous samples)
was observed.
We included possible confounding factors, including body mass
index (BMI), family history of breast cancer, self reported history
of benign breast disease, age, and menopausal status in all models
in the Nurses’ Health Study. We also used unconditional logistic
regression with the Women’s Health Study, controlling for age,
family history of breast cancer, and self reported history of benign
breast disease. Tests for interactions were performed using Wald
tests that include main effects and interaction terms in the model,
and likelihood ratio testing, comparing the fit of the model with
only main effects to the fit of the model with both main effects and
interaction terms. All statistical analyses were carried out using
SAS 9.1 (SAS Institute, Cary NC), with the exception of power
calculations which were performed in the Quanto software[24]
and pooled analyses which were performed using the rmeta
package in R. We analyzed the association between A10398G and
alcohol intake and breast cancer risk using unconditional logistic
regressions using Proc Logistic to include the greatest number of
case-control sets in interaction analyses. Alcohol consumption was
classified as ever/never due to the low level of consumption in
both cohorts. Cross-tabulated analyses were carried out by
creating indicator variables for each cell of the cross-classified
table, and fitting these indicator variables in the model. We
additionally examined the effect of alcohol consumption in strata
according to allele carrier status.
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